Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Sanda Buruiana"'
Autor:
Radu Andrei Tomai, Sabina Iluta, Adrian Bogdan Tigu, Madalina Nistor, Anamaria Bancos, Diana Cenariu, Ciprian Jitaru, Sergiu Patcas, Delia Dima, David Kegyes, Sanda Buruiana, Mihnea Zdrenghea, Alina Daniela Tanase, Ciprian Tomuleasa, Romeo Micu
Publikováno v:
Diagnostics, Vol 14, Iss 18, p 2084 (2024)
Background: Spontaneous remission of cancer is a rare and poorly understood phenomenon characterized by complete or partial remission of a malignancy in the absence of or with inadequate treatment. The underlying mechanism for such occurrences is poo
Externí odkaz:
https://doaj.org/article/779089795ffe47b0ba5502f004b08f6d
Autor:
Ivan Negara, Inga Chemencedji, Natalia Dobrovolschi, Natalia Sporis, Sanda Buruiana, Igor Vinogradov
Publikováno v:
Clinical Case Reports, Vol 12, Iss 4, Pp n/a-n/a (2024)
Key Clinical Message Identifying myeloid sarcoma in rare locations is a diagnostic challenge and requires careful evaluation. The optimal management of extramedullary disease requires further investigation, but tissue biopsy and a personalized approa
Externí odkaz:
https://doaj.org/article/4c35bbca5c59421eb154a8ee6cc0ec67
Publikováno v:
The Moldovan Medical Journal, Vol 66, Iss 1, Pp 77-82 (2023)
Background: Chronic lymphocytic leukemia (CLL) is a malignant lymphoproliferative, monoclonal, indolent hemopathy characterized by pathologically increased synthesis of mature but immunologically dysfunctional B lymphocytes. CLL is considered the pat
Externí odkaz:
https://doaj.org/article/9ccb9584ca804c229eb586d0945585fd
Autor:
Victor Tomacinschii, Adrian Mosquera Orgueira, Carlos Aliste Santos, Maria Robu, Sanda Buruiana, Maximo Francisco Fraga Rodriguez
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Next generation sequencing (NGS) is a technology that broadens the horizon of knowledge of several somatic pathologies, especially in oncological and oncohematological pathology. In the case of NHL, the understanding of the mechanisms of tumorigenesi
Externí odkaz:
https://doaj.org/article/d47864ff8c8b43699c65ac818dc39a1b
Publikováno v:
HemaSphere, Vol 7, p e885844a (2023)
Externí odkaz:
https://doaj.org/article/ebfc3945d99d49699e185da2358d2468
Autor:
Victor Tomacinschii, Maria Robu, Sanda Buruiana, Veronica Finciuc, Ana Grecu, Cristina Dudnic, Dumitrița Urescu, Marina Suschevici
Publikováno v:
The Moldovan Medical Journal, Vol 64, Iss 5, Pp 56-61 (2021)
Background: Non-Hodgkin’s lymphomas (NHL) are malignant tumors that develop from lymphoid tissue. Primary lymph node (LN) involvement is the most common localization (52-70%). The integration of Rituximab (R) in the NHL treatment represented a tur
Externí odkaz:
https://doaj.org/article/bf58d0a2acb043ddb05675af7e9cf73e
Publikováno v:
Archives of the Balkan Medical Union, Vol 56, Iss 3, Pp 336-341 (2021)
Introduction. Indolent non-Hodgkin lymphoma (NHL) is a lymphoid tumor with increasing morbidity with age. The objective of the study was to assess the clinical and hematological features of indolent NHL in elderly patients. Material and methods. Th
Externí odkaz:
https://doaj.org/article/2327181dccd1410d9116f6dd3bd47b99
Publikováno v:
Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol 66, Iss 2, Pp 114-117 (2020)
Din 62 pacienți cu limfom non-Hodgkin (LNH) aflați în staționar, Departamentul Hematologie a IMSPIO din RM, 47 au întrunit criteriile de includere în studiu. La vizita inițială vârsta medie a pacienților a fost de 64,1±1,3 (i-v 37-78) ani,
Externí odkaz:
https://doaj.org/article/b8046b29c1764106becc9a79421988a5
Publikováno v:
Archives of the Balkan Medical Union, Vol 55, Iss 3, Pp 418-423 (2020)
Introduction. Non-Hodgkin’s lymphoma (NHL) is a malignant cancer of the lymphatic system. Modern treatment of NHL allows patients to extend their lifespan, but at the same time somatic and psychological complications reduce the patients’ quality
Externí odkaz:
https://doaj.org/article/2c32681d4de84b9ea6505ec1c0381925
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S42- (2021)
Objective: Identification of hemostasis changes in patients with non-Hodgkin's lymphoma (NHL) and anticardiolipin antibodies (aCL). Methodology: The study included 83 patients (men-34, women-49) with a mean age of 63.2 years, with NHL, investigated c
Externí odkaz:
https://doaj.org/article/acdceef16bc1462c9fd4cf6fc4d45414